Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Cardiovascular disease news

Show

From To
People with HIV have impaired respiratory health, even when viral load is undetectable

HIV-positive people have impaired respiratory health, even when they have viral suppression with antiretroviral therapy (ART), investigators from London report in HIV Medicine. Respiratory health was compared between HIV-positive

Published
23 hours ago
By
Michael Carter
Curing hepatitis C reduces cardiovascular risk

Curing hepatitis C reduces the risk of cardiovascular events in people with compensated cirrhosis, a large French study presented this week at the International Liver Congress in

Published
20 April 2017
By
Keith Alcorn
HIV Infection, Heart Failure Go Together

HIV-positive individuals had an increased risk of several types of heart failure compared to individuals without the disease, a large epidemiologic study found.

Published
10 April 2017
From
MedPage Today HIV/AIDS
Are serious heart problems inevitable for people with HIV? A conversation with cardiologist Priscilla Hsue

Priscilla Hsue, MD, FACC, a cardiologist at Zuckerberg San Francisco General Hospital spoke about heart health and inflammation, and why cardiovascular conditions are becoming a growing concern for people growing older with HIV.

Published
16 March 2017
From
BETA blog
High prevalence and incidence of hypertension among rural Africans living with HIV

The research conducted by Swiss TPH is among the first longitudinal studies looking at the development of hypertension among people living with HIV in sub-Saharan Africa. In a cohort of 955 HIV-infected people, 111 (11.6%) were hypertensive.

Published
09 March 2017
From
EurekAlert (press release)
New antibody therapy “profoundly” successful at reducing inflammation from HIV

In a very small study of people living with HIV, a one-time antibody treatment significantly reduced the type of inflammation that can lead to heart attacks and other cardiovascular problems.

Published
09 March 2017
From
BETA blog
D:A:D study – long-term use of darunavir/ritonavir modestly increases the risk of cardiovascular disease

Long-term use of the protease inhibitor darunavir/ritonavir modestly increases the risk of cardiovascular disease, according to data from the ongoing D:A:D study presented to the recent Conference on

Published
08 March 2017
By
Michael Carter
Darunavir Associated with Heart Disease

But atazanavir use in HIV patients not linked to cardiovascular disease.

Published
20 February 2017
From
MedPage Today HIV/AIDS
Stopping smoking cuts the risk of some cancers quickly in people with HIV

Smoking probably contributes far more to the risk of cardiovascular disease in people with HIV than antiretroviral drug choice, viral load or any factor linked to the

Published
17 February 2017
By
Keith Alcorn
Vitamin D deficiency reduces statin potency, increases risk of muscle pain in people with HIV

People living with HIV who take statins are less likely to experience cholesterol reductions and more likely to develop painful muscle damage as a side-effect

Published
18 January 2017
By
Keith Alcorn
← First12345...24Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.